The Science Behind TMS and Depression
When depression persists, deciding what to do next can feel overwhelming. Understanding the neurobiology underlying depression can make your options clearer. That is why, at Desert View Counseling, we explain the science behind TMS and depression—from how TMS engages mood-related brain circuits to how this non-invasive technology fits into evidence-based care.
How Magnetic Pulses Influence Your Mood Circuits
The science that explains depression, which TMS can treat, involves changes in activity and connectivity across networks that include the dorsolateral prefrontal cortex and deeper limbic structures. TMS therapy applies a precisely controlled magnetic pulse to the surface cortex. This pulse induces small electrical changes in neurons, which can modulate synaptic strength and network communication over repeated sessions. Over time, this repeated stimulation supports neuroplasticity—the brain’s ability to adapt—so mood-related circuits can function more effectively.
What Does TMS Therapy Look Like in Practice?
The targeted approach of TMS treatment to address depression is similar in principle to MRI technology, but focused for therapeutic stimulation. You remain awake, there is no anesthesia, and treatment does not introduce a systemic drug into the body. Results typically build gradually across several weeks, and benefits can last up to 12 months, which is why we schedule follow-ups to track progress and guide your next steps (Dunner DL, et al., 2014. J Clin Psychiatry, 75(12):1394-1401).
What the Evidence Shows About Outcomes
Real-world data helps set expectations about TMS treatment and depression. According to a large outcomes registry drawn from varied clinics and patient backgrounds, 83 percent of patients experienced improvement with NeuroStar TMS (Sackeim HA et al., 2020). The clinical outcomes of TMS for depression: A large registry study. Journal of Affective Disorders, 277(12):65–74). These results align with the belief that repeated cortical stimulation can produce symptom relief through circuit-level changes rather than whole-body drug exposure.
Medication remains an important option for many people. However, findings from the STAR*D program show that with each additional antidepressant trial, the likelihood of remission tends to decrease while the chance of stopping due to common side effects increases. This context is why people often consider a device-based path, such as TMS, as part of a comprehensive plan (results from the STAR*D study, medication attempts (n=4,041): Trivedi 2006; Rush 2006; Fava 2006; McGrath 2006; Am J Psychiatry).
Safety, Sensation, and Who May Be a Suitable Candidate
Following scientific research into the effectiveness and safety of NeuroStar TMS therapy, it has been FDA-cleared for major depressive disorder in adults, and we consider this treatment for patients aged 15 and up at our practice. There is a moderate risk of side effects. These most often include temporary scalp discomfort or headache around treatment times. For obsessive-compulsive disorder, TMS therapy is an adjunct treatment, so patients should continue their current therapies.
At your consultation, we will focus on your history, prior medication trials, and goals. Together, we will determine whether a non-invasive, device-based approach aligns with your preferences and schedule, and outline how we can measure progress throughout the course of treatment.
Contact Us To Explore the Latest Research on TMS and How It Can Treat Depression
If you want a science-first, compassionate explanation of options, our team will walk you through the details and help you decide on next steps. Contact us to learn about the science behind TMS and depression, and whether this treatment could be suitable for you.
